Thiamine Mononitrate 300 mg for heart failure

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 24 May 2023: Trial registered, NCT05873881
  2. 29 Jan 2024: Trial started, NCT05873881

The trials

NCT05873881: COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease

State
Under way
Phase
Phase 3
People
2,500 planned
Started
29 Jan 2024
Primary completion
Jun 2027
Arms
Thiamine versus no thiamine
Results
None posted
  1. 24 May 2023: Trial registered
  2. 29 Jan 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.